A clinical trial involving leptin has been updated as of September 25, 2026. The study, registered as NCT03697577 and titled "CDK and Body Composition Study," is now listed with a status of COMPLETED. No phase was specified for this trial in the available record. Leptin currently holds approved regulatory status. This update reflects only the trial's status designation as recorded on ClinicalTrials.gov and does not include any reported outcomes or results. No efficacy or safety findings have been disclosed as part of this status change. Readers should note that a completed status indicates the study has concluded according to its registered protocol, not that specific results have been published or reviewed. Further details on trial design, endpoints, or findings, if and when released, would appear as separate updates to the registry entry. Those interested in the background of this compound, including its established approved use, can consult the compound overview for additional context.
Leptin Trial "CDK and Body Composition Study" Marked Completed
Source: https://clinicaltrials.gov/study/NCT03697577